Financials disclosed in this offering
FY2022–FY2023 · hover for sourceThe fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.
Amendments to this offering
4 amendments- May 20, 2025
- Apr 29, 2025
- Deadline Apr 30, 2025 → Jun 30, 2025
“ssuer is updating their financial statements per the most recent fiscal year and extending their campaign end date to June 30th, 2025.”
Form C/A on EDGAR ↗ - Apr 9, 2025
- Feb 28, 2025
- Deadline Apr 28, 2025 → Apr 30, 2025
- Maximum $124K → $1.2M
- Target $124K → $20K
“Updated financials, added CEO dual work disclosures, updated principal shareholder voting to 82%, updated shares outstanding/valuation, revised product availability, clarified IP ownership/corp. conversion, adj. offering amounts, extended the deadline.”
Form C/A on EDGAR ↗
Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.
Deal terms
Perks
Offering details
Links & provenance
0001665160-25-000149
Last synced Aug 18, 2026
About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.